Our unique methodology identifies spillover effects from one managed segment (for example Medicaid, Medicare D or hospitals) to the commercial third party segment in your product category. The analysis estimates the magnitude of expected spillover market share for your product under various formulary scenarios.
We estimate the impact of a favorable formulary position on both the managed segment share and third party commercial share, allowing you to make informed decisions with respect to contracting.
Deliverables: Detailed analysis by state, MSA, sales area, or other geography. Break even analyses to determine rebate guidelines. Strategic recommendations.